Référence - Les opiacés et la sédation palliative ne tuent pas

1. Ventafridda, V., et al., Symptom prevalence and control during cancer patients' last days of life. J Pall Care, 1990. 6: p. 7-11.

2. Forbes, K., Opioids: beliefs and myths. J Pain Palliat Care Pharmacother, 2006. 20(3): p. 33-5.

3. Bates J., Gwyther L., and Dinat N., Morphine: friend or foe? Malawi medical journal, 2008. 20: p. 112-4.

4. Billings, J.A. and S.D. Block, Slow euthanasia. J Pall Care, 1996. 12: p. 21-30.

5. Ergmayer, P.K., A message of hope to those in painful expectation of death. New Zealand Medical J, 2001: p. 167.

6. Pattinson, K., Opioids and the control of respiration. Br J Anaesth, 2008. 100: p. 747-58.

7. Cote, J.N. and M.K. Hoeger Bement, Update on the relation between pain and movement: consequences for clinical practice. Clin J Pain, 2010.

8. Schofield, P. and B. Davis, Sensory deprivation and chronic pain: a review of the litterature. Disabil Rehabil, 1998. 20(10): p. 357-66.

9. Janssen, D.J.A., et al., A dosage of opioids should never exceed what is necessary to releive symptoms. Am J Resp Care Med, 2008. 178: p. 1186.

10. Baust, G., [Does morphine have a life-shortening effect?]. MMW Fortschr Med, 2008. 149 Suppl 4: p. 144-7.

11. Rurup, M.L. and B.D. Onwuteaka-Philipsen, Relieving pain and suffering does not hasten death. Crit Care Med, 2008. 36(8): p. 2486-7.

12. Thorns A, S.N., Opioid use in last week of life and implications for end-of-life decision-making. Lancet, 2000. 356: p. 398-9.

13. Morita T, T.J., Inoue S, Effects of high dose opioids and sedative on survival in terminally ill cancer patients. J Pain Symptom Management, 2001. 21: p. 282-9.

14. Bercovitch M, A.A., Patterns of high-dose morphine use in a home-care hospice service. Cancer, 2004. 101: p. 1473-7.

15. Bengoechea, I., et al., Opiods use at the end of life and survival in a hospital at home unit. J Pall Medicine, 2010. 13: p. 1079-83.

16. Portenoy, R.K., et al., Opioid use and survival at the end of life: a survey of a hospice population. J Pain Symptom Management, 2006. 32: p. 535-40.

17. Ryan M, M.T., Loprinzi CE, As-needed morphine: yes, but at what dose and at what interval? J Clin Oncol, 2005. 23: p. 3849-52.

18. Sykes, N. and A. Thorns, The use of opioids and sedatives at the end of life. Lancet, 2003. 4: p. 312-18.

19. van der Heide A. Onwuteaka-Philipsen BD, R.M., Buiting HM, van Delden JJ et al, End-of-life practices in the Netherlands under the euthanasia act. New Eng J Med, 2007. 356: p. 1957-65.

20. Euthanasia: a 'kit' sold in Belgian pharmacies. Prescrire International, 2005. 79: p. 197.

21. Morita T, Akechi T, and Ikenaga M, Late referrals to specialized palliative care service in Japan. J Clin Oncol, 2005. 23: p. 2367-44.

22. Zimmermann C, R.R., Krzyzsanowska M, Rodin G, Tannock I, Effectiveness of specialized palliative care: a systematic review. JAMA, 2008. 299: p. 1698-709.

23. Temel JS, G.J., Muzikanski MA et al, Early palliative care for patients with metastatic non-small-cell lung cancer. New Eng J Med, 2010. 363: p. 733-42.

24. Forbes, K. and R. Huxtable, Clarifying the data on double effect. Pall med, 2006. 4: p. 395-6.

25. Rurup, M., et al., Trends in the use of opioids at the end of life and the expected effects of hastening death. J Pain Symptom Management, 2009. 37: p. 144-55.

26. Douglas, C., I. Kerridge, and R. Ankeny, Managing intentions: the end-of-life administration of analgesics and sedative and the possibility of slow euthanasia. Bioethics, 2008. 22: p. 388-96.

27. Lo B, R.G., Palliative sedation in dying patients. JAMA, 2005. 294: p. 1810-16.

28. Rietjens JA, v.D.J., van der heide A etb al, Terminal sedation and euthanasia: a comparison of clinical practices. Arch Int Med, 2006. 166: p. 749-53.

29. George R, R.C., Lethal opioids or dangerous prescribers? Pall med, 2007. 21: p. 77-80.

30. The ethics of palliative sedation as a therapy of last resort. Am J Hosp Palliat Care, 2006. 23(6): p. 483-91.

31. Billings JA, B.S., Slow euthanasia. J Pall Care, 1996. 12: p. 21-30.

32. Rietjens, J.A., et al., Terminal sedation and euthanasia: a comparison of clinical practices. Arch Int Med, 2006. 166: p. 749-53.

33. Sprung CL, L.D., Bulow H, Lipperts A et al, Relieving suffering or intentionally hastening death: where do you draw the line. Crit Care Med, 2008. 36: p. 8-13.

34. Rurup M, B.S., van der Heide A, van der Maas PJ, Onwuteaka-Philipsen BD, Trends in the use of opioids at the end of life and the expected effects of hastening death. J Pain Symptom Management, 2009. 37: p. 144-55.

35. Regnard C, F.I., Releiving suffering or hastening death: a misrepresentation. Crit Care Med, 2008. 36: p. 2484.

36. Koogler TK, H.K., Euthanasia , eye of the beholder. Crit Care Med, 2008. 36: p. 331.

37. Claessens, P., et al., Palliative sedation: a review of the research literature. J Pain Symptom Manage, 2008. 36(3): p. 310-33.

38. Engstrom, J., et al., Palliative sedation at end of life - a systematic literature review. Eur J Oncol Nurs, 2007. 11(1): p. 26-35.

39. Sykes N, T.A., The use of opioids and sedatives at the end of life. Lancet, 2003. 4: p. 312-18.

40. Maltoni M, P.C.S.L., Martini F, Turci P, Montanari L, Nanni O, Palliative sedation therapy does not hasten death: results from a prospective multicenter study. Annals of oncology, 2009. 20: p. 1163-69.

41. Meterstvedt LJ, C.D., Ellershaw J et al, Euthanasia and physician-assisted suicide: a view from an EAPC Ethics task Force. Palliat Med, 2003. 17: p. 97-101.

42. George, J.A., et al., The effect of intravenous opioid patient-controlled analgesia with and without background infusion on respiratory depression: a meta-analysis. J Opioid Manag. 6(1): p. 47-54.

43. Walsh, T.D., N.I. Rivera, and R. Kaiko, Oral morphine and respiratory function amongst hospice inpatients with advanced cancer. Support Care Cancer, 2003. 11(12): p. 780-4.

44. Estfan, B., et al., Respiratory function during parenteral opioid titration for cancer pain. Palliat Med, 2007. 21(2): p. 81-6.

45. Gallagher, R., Killing the symptom without killing the patient. Can Fam Physician, 2010. 56: p. 544-46.

46. Mogri, M., et al., Hypoxemia in patients on chronic opiate therapy with and without sleep apnea. Sleep Breath, 2009. 13(1): p. 49-57.

47. Sumida, S., et al., Meta-analysis of the effect of extended-release epidural morphine versus intravenous patient-controlled analgesia on respiratory depression. J Opioid Manag, 2009. 5(5): p. 301-5.

48. Douglas C, K.I., Ankeny R, Managing intentions: the end-of-life administration of analgesics and sedative and the possibility of slow euthanasia. Bioethics, 2008. 22: p. 388-96.

49. Cavanaugh, T.A., The ethics of death-hastening or death causing palliative analgesic administration to the terminally ill. J Pain Symptom Management, 1996. 12: p. 248-54.

50. Clark PA, Morphine vs ABT-594: a reexamination by the principle of double effect. Linacre quarterly, 2003: p. 109-20.

51. Regnard C, Double effect is a myth leading to a double life. BMJ, 2007. 334: p. 440.